Search results for "PLACEBO"

showing 10 items of 704 documents

Reproducibility of irritant patch test reactions to sodium lauryl sulfate in a double-blind placebo-controlled randomized study using clinical scorin…

1999

Reading of doubtful patch test reactions can be improved by comparing them to defined negative, allergic and irritant controls. For the latter, an irritant patch test is needed that gives sufficiently reproducible results. In our double-blind, placebo-controlled. randomized study, we have analysed the synchronous reproducibility of patch tests with 0%, 0.0625%, 0.125%, 0.25%, 0.5% and 1.0% sodium lauryl sulfate (SLS). Tests and readings were done according to ESCD guidelines. 139 patients (75 women, 64 men) 18 to 77 years old were tested. The % of positive patients as well as the % of reproducible positive reactions increased with rising concentrations of SLS to a maximum of approximately 9…

irritancyAdultMalemedicine.medical_specialtyAdolescentSodiumchemistry.chemical_elementDermatologyPlacebomedicine.disease_causesurfactantsStatistics Nonparametriclaw.inventionSurface-Active AgentsRandomized controlled trialDouble-Blind MethodlawmedicineImmunology and AllergyHumanscontrolssodium lauryl sulfateAgedReproducibilityintegumentary systemChemistryPatch testReproducibility of ResultsSodium Dodecyl SulfateMiddle AgedPatch Testsmedicine.diseaseDermatologypatch testing techniqueSurgeryToxicityIrritantsFemaleIrritationContact dermatitispatch testContact dermatitis
researchProduct

Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a random…

2010

Abstract Background Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with purified natural Alt a1 and its effect on airway responsiveness to direct and indirect bronchoconstrictor agents and markers in exhaled air. Methods This was a randomized double-blind trial. Subjects with allergic rhinitis with or without mild/moderate asthma sensitized to A alternata and who also had a positive skin prick test to Alt a1 were randomized to treatment with placebo (n = 18) or purified natural Alt a1 (n = 22) subcutaneously for 12 months. Bronchial respons…

lcsh:Immunologic diseases. AllergyPulmonary and Respiratory Medicinemedicine.medical_specialtyPathologyAllergybusiness.industrymedicine.medical_treatmentResearchInflammationGeneral MedicineImmunotherapyPlacebomedicine.diseaseGastroenterologyInternal medicineExhaled nitric oxidemedicineImmunology and AllergyMethacholineExhaled breath condensatemedicine.symptomAdverse effectbusinesslcsh:RC581-607medicine.drugAllergy, Asthma & Clinical Immunology
researchProduct

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled rando…

2019

Abstract Background Hereditary angioedema (HAE) is a debilitating disorder resulting from C1-esterase inhibitor (C1-INH) deficiency. In the COMPACT phase 3 study the prophylactic use of a subcutaneous C1 inhibitor (C1-INH [SC], HAEGARDA®, CSL Behring) twice weekly significantly reduced the frequency of acute edema attacks. Analysis of treatment effects by subgroups, onset of effect, and other exploratory analysis have not been reported. Methods This is a post hoc exploratory analysis on data from the randomized, placebo-controlled COMPACT study. 90 patients with C1-INH-HAE were randomized to 1 of 4 treatment sequences: C1-INH (SC) 40 or 60 IU/kg of body weight twice weekly for 16 weeks, pre…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyPhases of clinical researchSubgroup analysisReplacement therapyPlacebolaw.invention03 medical and health sciences0302 clinical medicineC1-INH (SC)Randomized controlled trialHAEGARDA®lawInternal medicinePost-hoc analysisMedicine030212 general & internal medicineDosingCOMPACT studyHereditary angioedemabusiness.industryResearchSubcutaneousGeneral Medicinemedicine.diseaseClinical trialLong-term prophylaxis030228 respiratory systemC1-esterase inhibitor proteinHereditary angioedemabusinesslcsh:RC581-607Allergy, Asthma & Clinical Immunology
researchProduct

Effects of soluble milk protein or casein supplementation on muscle fatigue following resistance training program: a randomized, double-blind, and pl…

2014

International audience; Background: The effects of protein supplementation on muscle thickness, strength and fatigue seem largely dependent on its composition. The current study compared the effects of soluble milk protein, micellar casein, and a placebo on strength and fatigue during and after a resistance training program. Methods: Sixty-eight physically active men participated in this randomized controlled trial and underwent 10 weeks of lower-body resistance training. Participants were randomly assigned to the Placebo (PLA), Soluble Milk Protein (SMP, with fast digestion rate) or Micellar Casein (MC, with slow digestion rate) group. During the 10-week training period, participants were …

medicine.medical_specialty030309 nutrition & dieteticsPlacebo-controlled studyEXERCISE[SDV.GEN] Life Sciences [q-bio]/GeneticsClinical nutritionBioinformaticsPlaceboCHAIN AMINO-ACIDSlaw.inventionEndurance03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineCaseinCARBOHYDRATEmedicine[SDV.GEN]Life Sciences [q-bio]/Genetics0303 health sciencesNutrition and DieteticsMilk proteinMuscle fatigueATTENUATES FATIGUEbusiness.industry030229 sport sciencesN-ACETYLCYSTEINEPERFORMANCEBranched-chain amino acidsHYPERTROPHYEndocrinologyMuscle powerADAPTATIONSMuscle thicknessSKELETAL-MUSCLE[ SCCO ] Cognitive scienceDigestionbusiness[ SDV.GEN ] Life Sciences [q-bio]/GeneticsResearch ArticleFood ScienceINGESTION
researchProduct

Herbal medications for anxiety, depression, pain, nausea and vomiting related to preoperative surgical patients: a systematic review and meta-analysi…

2019

ObjectiveTo summarise the effects of herbal medications for the prevention of anxiety, depression, pain, and postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic, obstetrical/gynaecological or cardiovascular surgical procedures.MethodsSearches of MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and LILACS up until January 2018 were performed to identify randomised controlled trials (RCTs). We included RCTs or quasi-RCTs evaluating any herbal medication among adults undergoing laparoscopic, obstetrical/gynaecological or cardiovascular surgeries. The primary outcomes were anxiety, depression, pain and PONV. We used the Grading of Recommendations Assessme…

medicine.medical_specialty1685NauseaPainAnxietyPlacebo03 medical and health sciences0302 clinical medicinegynecologic surgerysystematic review030202 anesthesiologyInternal medicinePreoperative CaremedicineHumans030212 general & internal medicine1506Adverse effectRandomized Controlled Trials as Topiccardiovascular surgerybusiness.industryDepressionResearchherbal laparoscopyGeneral MedicineGRADEMeta-analysisRelative riskPostoperative Nausea and VomitingVomitingAnxietyComplementary Medicineobstetrical surgeryPlant Preparationsmedicine.symptombusinessPostoperative nausea and vomitingPhytotherapyBMJ open
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct

Randomized, placebo-controlled, double-blind and open-label studies in the treatment and prevention of acute diarrhea with Enterococcus faecium SF68

2020

Enterococcus faecium SF68® (SF68) is a licensed pharmaceutical for treatment and prevention of diarrhea in Austria, Italy and Switzerland. However, as for other probiotics, evidence for its efficacy is based on small to medium-sized studies. Four unpublished studies on the treatment of acute diarrhea and the prevention of antibiotic-associated diarrhea were analyzed: one randomized, double blind, placebo-controlled trial (RCT) for treatment (n = 1,143), one open-label study for treatment (n = 5,093), one RCT for prevention (n = 1,397) and one open-label study for prevention (n = 4,340). Patients in the treatment-arm and the open-label studies received SF68 (b.i.d. for the prevention studies…

medicine.medical_specialtyAcute diarrheaEnterococcus faecium610 Medicine & health2700 General Medicinerandomized-controlled trialPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlawInternal medicinemedicineClinical endpoint030212 general & internal medicineAdverse effectOriginal Researchlcsh:R5-920biologytreatmentbusiness.industryIncidence (epidemiology)SF68acute diarrheaGeneral Medicinebiology.organism_classificationDiarrhea10219 Clinic for Gastroenterology and HepatologyprobioticsMedicine030211 gastroenterology & hepatologymedicine.symptomlcsh:Medicine (General)businessEnterococcus faecium
researchProduct

Effectiveness of tDCS at Improving Recognition and Reducing False Memories in Older Adults

2021

Background: False memories tend to increase in healthy and pathological aging, and their reduction could be useful in improving cognitive functioning. The objective of this study was to use an active–placebo method to verify whether the application of transcranial direct current stimulation (tDCS) improved true recognition and reduced false memories in healthy older people. Method: Participants were 29 healthy older adults (65–78 years old) that were assigned to either an active or a placebo group

medicine.medical_specialtyAgingHealth Toxicology and Mutagenesismedicine.medical_treatmentlcsh:Medicinetrue recognitionAudiologyTranscranial Direct Current StimulationPlacebo group050105 experimental psychologyArticle03 medical and health sciences0302 clinical medicineMemorymedicineGroup interactionHumans0501 psychology and cognitive sciencesCognitive skillAgedAged 80 and overTranscranial direct-current stimulationMemory errorsRecallexperimentbusiness.industry05 social scienceslcsh:RPublic Health Environmental and Occupational HealthRecognition Psychologyfalse recognitionFalse recognitionMental RecallbusinessOlder people030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review

2017

Background Guidelines and position papers indicate that allergen immunotherapy (AIT) is the only disease-modifying treatment, including prevention of the onset of new allergen sensitizations. However, this preventive effect was shown by only a few observational studies. Our aim was to systematically review the efficacy of AIT in preventing the onset of new allergen sensitizations. Methods Computerized bibliographic searches of MEDLINE, EMBASE, and the Cochrane Library (through June 2015) were supplemented with manual searches of reference lists. Observational studies or randomized controlled trials with a long-term observation period were included. Paired reviewers extracted data about stud…

medicine.medical_specialtyAllergen immunotherapyImmunologyMEDLINECochrane Librarymedicine.disease_causePlacebolaw.invention03 medical and health sciences0302 clinical medicineAllergensystematic reviewRandomized controlled triallawInternal medicineHypersensitivityOdds RatiomedicineAnimalsHumansImmunology and Allergy030212 general & internal medicinebusiness.industryAbsolute risk reductionasthmaAllergensImmunoglobulin ErhinoconjunctivitiSurgeryGRADETreatment Outcome030228 respiratory systemDesensitization Immunologicallergen immunotherapyImmunizationObservational studybusinessAllergy
researchProduct

Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A systematic review and meta-analysis

2010

Background The benefit of sublingual immunotherapy (SLIT) with grass allergens for seasonal allergic rhinitis has been extensively studied, but data on efficacy are still equivocal. Objective To assess the effectiveness of SLIT with grass allergens in the reduction of symptoms and medication in patients with seasonal allergic rhinitis to grass pollen. Methods Computerized bibliographic searches of MEDLINE (1995-2010) were supplemented by hand searches of reference lists. Studies were included if they were double-blind randomized controlled trials (RCTs) comparing SLIT to placebo and if they included patients with history of allergy to grass pollen treated with natural grass pollen extracts.…

medicine.medical_specialtyAllergyMEDLINEImmunologyAdministration SublingualPlaceboPoaceaelaw.inventionSublingual administrationRandomized controlled triallawInternal medicineotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansSublingual immunotherapy rhinitis grass meta-analysisAdverse effectRandomized Controlled Trials as Topicbusiness.industryfood and beveragesRhinitis Allergic Seasonalmedicine.diseaseSlitTreatment OutcomeStrictly standardized mean differenceMeta-analysisImmunologyPollenImmunotherapybusiness
researchProduct